Total body irradiation

Reports of Practical Oncology and Radiotherapy

Volumn 4, Issue 3, 1999, Pages 47-64

  Barrett, A ^a  

^a BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

Author keywords

Total body irradiation

Indexed keywords

EID: 0002796494     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1507-1367(99)70316-0     Document Type: Article

References (80)

1. Abrams R A, Liu P J C, Ambinder R F et al. Hodgkin and Non-Hodgkin Lymphoma: Local-regional radiation therapy after bone marrow transplantation. Radiology 1997,203: 865-870.
2. Applebaum F R, Clift R, Radich J, Anasetti C, Buckner C D. Bone marrow transplantation for chronic myelogenous leukaemia. Seminars in Oncology 1995, 22 (4): 405-411.
3. Baglin T P. Veno-occlusive disease of the liver complicating bone marrow transplantation. Bone Marrow Transplantation 1994, 13:1.
4. Barrett A J, Horowitz M M, Pollock B H, Zhang M J, Bortin M M, Buchanan G R, Camitta B M, Ochs J, Graham-Pole J, Rowlings P A, Rimm A A, Klein J P, Shuster J J, Sobocinski K A, Gale R P. Bone marrow transplantation from HLA - identical siblings as compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission. New England Journal of Medicine 1994, 331: 1253.
5. Barrett A, Jacobs A, Kohn J, Rayman J, Powles R L. Changes in serum amylase and its isoenzymes after whole body irradiation. British Medical Journal 1982, 285: 170-1.
6. Barrett A. Total body irradiation (TBI) before bone marrow transplantation in leukaemia. British Journal of Radiology 1982, 55: 562-5.
7. Bergstein J, Andreoli S P, Provisor A J, Yum M. Radiation nephritis following total body irradiation and cyclophosphamide in preparation for bone marrow transplantation. Transplantation 1986, 41: 63·6.
8. Bortin M M, Horowitz M M, Rimm A A. Progress report from the International Bone Marrow Transplant Registry. Bone Marrow Transplant 1992, 10: 113-122.
9. Bortin M M, Kay H E, Rimm A A, Gale R P. Factors associated with interstitial pneumonitis after bone marrow transplantation for acute leukaemia. Lancet 1982, ii: 437-9.
10. Brenner M K, Rill D R, Heslop H E, Roney C M, Roberts W M, Li C, Nilson T, Krance R A.. Gene marking after bone marrow transplantation. European Journal of Cancer 1994, 30A: 1171-1176.
11. Chaoul H, Lange K. Ueber Lymphogranulomatose und ihre Behandlung mit Rontgenstrahlen. Munchener Medizinische Wochenschrift 1923, 23: 725-7.
12. Curtis R E, Rowlings P A, Deeg H J, Shriner D A, Socie G, Travis L B, Horowitz M M, Witherspoon R P, Hoover R N, Sobocinski K A, Fraumeni J F Jr, Boice J D Jr. Solid cancers after bone marrow transplantation. The New England Journal of Medicine 1997, 336 (13): 897-904.
13. Dahllöf G, Bågesund M, Ringdén O. Impact of conditioning regiments on salivary function, cariesassociated microorganisms and dental caries in children after bone marrow transplantation. A 4-year longitudinal study. Bone Marrow Transplantation 1997,20: 479-483.
14. Darrington D L, et al. Incidence and characterization of secondary myelodysplastic syndrome and acute myelogeneous leukaemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. Clinical Oncology 1994, 12: 2527-2534.
15. Dausset J, Nenna A. Présence d'une leucoagglutinine dans Ie serum d'un cas d'agranulocytose chronique. Comptes Rendues de la Societe Biologique 1952, 146: 1539-41.
16. Deeg H J, Flournoy N, Sullivan K M, Sheehan K, Buckner C D, Sanders J E, Storb R, Witherspoon R P, Thomas E D. Cataract after total body irradiation and marrow transplantation: a sparing effect of dose fractionation. International Journal of Radiation Oncology - Biology - Physics 1984, 10: 957-64.
17. Demirer T, Petersen F B, Appelbaum F R, Barnett T A, Sanders J, Deeg H J, Storb R, Doney K, Bensinger W I, Shannon-Dorey K, et al. Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies. International Journal of Radiation Oncology, Biology and Physics 1995, 32 (4): 11031109.
18. Dutreix J, Janoray P, Brider A, Houlard J P, Cosset J M. Biologic and anatomic problems of lung shielding in whole-body irradiation. Journal of the National Cancer Institute 1986, 76: 1333-5.
19. Ekstrand K, Greven K, Wu Q. The influence of x - ray energy on lung dose uniformity in total body irradiation. International Journal of Radiation Oncology - Biology - Physics 1997, 38 (5): 11311136.
20. Fife K, Milan S, Westbrook K, Powles R, Tait D. Risk factors for requiring cataract surgery following total body irradiation. Radiotherapy and Oncology 1994, 33 (2): 93-98.
21. Girinsky T, Socie G, Cosset J M, Malaise E P. Blood lymphocyte subsets after the first fraction in patients given hyperfractionated total body irradiation for bone marrow transplantation. British Journal of Cancer 1991,63: 646-647.
22. Gordon B G, Warkentin P I, Strandjord S E, Abromowitcg M, Bayever E, Harper J L, Coccia P F. Allogeneic bone marrow transplantation for children with acute leukaemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation. Bone Marrow Transplantation 1997,20: 5-10.
23. Heublein A C. A preliminary report on continuous irradiation of the entire body. Radiology 1932, XVIII: 1051-62.
24. Hjiyiannakis P, Metha J, Milan S, Powles R, Hinson J, Tait D. Melphalan, single fraction total body irradiation and allogeneic bone marrow transplantation for acute leukaemia: Review of transplant related mortality. Leukemia and Lymphoma 1997, 25: 565-572.
25. Hovi L, Tapanainen P, Saarinen-Pihkala U M, Siimes M A. Impaired androgen production in female adolescents and young adults after total body irradiation prior to BMT in childhood. Bone Marrow Transplantation 1997, 20: 561-565.
26. Huma Z, Boulad F, Black P, Heller G, Skalar C. Growth in children after bone marrow transplantation for acute leukaemia. Blood 1995, 86 (2): 819-824.
27. Keane T J, Van Dyke J, Rider W D. Idiopathic interstitial pneumonia following bone marrow transplantation: the relationship with total body irradiation. International Journal of Radiation Oncology - Biology - Physics 1981, 7: 1365·70.
28. Kernan N A, Bartsch G, Ash R C, Beatty P G, Champlin R, Filipovich A, Gajewski J, Hansen J A, Henslee-Downey J, McCullough J, McGlave P, Perkins H A, Philips G L, Sanders J, Stroncek D, Thomas E D, Blume K G. Analysis of 452 transplantations from unrelated donors facilitated by the National Marrow Donor Programme. New England Journal of Medicine 1993, 328: 593-602.
29. Kim T H, Rybka W B, Lehnert S, Podgorsak E B, Freeman C R. Interstitial pneumonitis following total body irradiation for bone marrow transplantation using two different dose rates. International Journal of Radiation Oncology - Biology - Physics 1985, 11: 1285-91.
30. Korbling M, Huh Y O, Durett A, Mirza N, Miller P, Engel H, Anderlini P, Van Besien K, Andreeff M, Przepiorka D et al. Allogeneic stem cell transplantation: peripheralization and yield of donorderived primitive hemopoietic progenitor cells (C034 + Thy-1 dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995, 86: 2842.
31. Kumar M, Saleh A, Rao P V, Ochoa S, Meyers L, Miller A, Graham-Pole J. Toxicity associated with high dose cytosine arabinoside and total body irradiation as conditioning for allogeneic bone marrow transplantation. Bone Marrow Transplantation 1997, 19: 1061-1064.
32. Kupari M, Volin I, Suokas A, Timonen T, Hekali P, Ruutu T. Cardiac involvement in bone marrow transplantation. Bone Marrow Transplantation 1990, 5 (2): 91-98.
33. Lapidot T, Singer T S, Salomon O, Terzi A, Schwartz E, Reisner V. Booster irradiation to the spleen following total body irradiation. Journal of Immunology 1988, 141: 2619-24.
34. Lewis M A, Rosenbloom M E. A double-headed cobalt - 60 unit for large field irradiation. British Journal of Radiology 1988, 61: 1192-5.
35. Lutz W R, Dougan P W, Bjarngard B E. Design and characteristics of a facility for total body and large field irradiation. International Journal of Radiation Oncology - Biology - Physics 1988, 15: 1035-40.
36. Medinger F G, Graver L F. Total body irradiation with review of cases. American Journal of R6ntgenology and Radiotherapy 1942, 48: 651-71.
37. Miralbell R, Bieri S, Mermillod B, Helg C, Sancho G, Pastoors B, Keller A, Kurtz J M, Chapuis B. Renal toxicity after allogeneic bone marrow transplantation. Journal of Clinical Oncology 1996,14(2): 579-585.
38. Moolten D N. Peripheral blood stem cell transplant: future directions. Seminars in Oncology 1995, 22: 271.
39. Nademanee A, O'Donnell M R, Snyder D S, Schmidt G M, Parker P M, Stein A S, Smith E P, Molina A, Stepan D E, Somlo G et al. High dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease. Results in 85 patients with analysis of prognostic factors. Blood 1995, 85: 1381.
40. Nakayama V, Makino S, Fukuda V, Min K, Shimizu A, Ohsawa N. Activation of lavage lymphocytes in lung injuries by radiotherapy for lung cancer. International Journal of Radiation Oncology - Biology - Physycs 1996,34(2): 459-467.
41. Nasman M, Forsberg CoM, Dahllöf G. Long term dental development after treatment for malignant disease. European Journal of Orthodontics 1997, 19: 151-159.
42. Nygaard R, et al. Second malignant neoplasms in patients treated for childhood leukaemia. Acta Paediatr Scand 1991, 80: 1220-1228.
43. O'Donoghue J A. Fractionated versus low dose rate total body irradiation. Radiobiological considerations in the selection of regiments. Radiotherapy and Oncology 1986,7: 242-7.
44. Patzer L, Hempel L, Ringelmann F, Misselwitz J, Fuchs 0, Zintl F, Brandis M, deBroe M E, Zimmerhackl L B. Renal function after conditioning therapy for bone marrow transplantation in childhood. Medical and Pediatric Oncology 1997, 28: 274-283.
45. Peper M, Schraube P, Kimmig B, Wagensommer C, Wannenmacher M, Haas R. Long term cerebral effects of total body irradiation and quality of life. In Recent Results in Cancer Research 1993, vol. 130: 219-230.
46. Peters I J, Withers H R, Cundiff J H, Dicke K A. Radiobiological considerations in the use of total body irradiation for bone marrow transplantation. Radiology 1979,131: 243-7.
47. Petersen F B, Deeg H J, Buckner CD, Appelbaum F R, Storb R, Clift R A, Sanders J E, Bensinger W I, Witherspoon R P, Sullivan K M, et al. Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide. International Journal of Radiation Oncology, Biology, and Physics 1992, 23: 1027-103.
48. Philip T, Guglielmi C, Hagenebeek A, Somers R, Van Oer Lelie H, Bron D, Sonneveld P, Gisselbrecht C, Cahn J V, Harousseau J L, Coiffier B, Biron P, Mandelli F, Chauvin F. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapse of chemotherapy - sensitive non-Hodgkin's lymphoma. New England Journal of Medicine 1995, 333: 1540-1545.
49. Pino Y, Torres J L, Bross D S, Lam W-C, Wharam M D, Santos G W, Order S E. Risk factors in interstitial pneumonitis following allogeneic bone marrow transplantation. International Journal of Radiation Oncology - Biology - Physics 1982, 8: 1301-7.
50. Quast U. Total body irradiation - a review of treatment techniques in Europe. Radiotherapy and Oncology 1987,9: 91-106.
51. Ringdén 0 et al. Increased mortality by septicaemia, interstitial pneumonitis and pulmonary fibrosis among bone marrow transplant recipients receiving an increased mean dose rate of total irradiation. Acta Radiologica et Oncologica 1983, 22: 421-8.
52. Ringdén O, Ruutu T, Remberger M. A randomized trial comparing busulphan and total body irradiation in allogeneic marrow transplant recipients with haematological malignancies. Transplantation Proceedings 1994, 26 (3): 1831-1832.
53. Rohatiner A Z, Johnson P W, Price C G, Arnott S J, Amess J A, Norton A J, Dorey E, Adams K, Whelan J S, Matthews J, et al. Myeloablative therapy with autologous bone marrow transplantation therapy for recurrent follicular lymphoma. Journal of Clinical Oncology 1994,12: 1177-1184.
54. Rosalia M et al. High dose cyclophosphamide, fractionated total body irradiation with involved field irradiation and autologous bone marrow transplantation in malignant lymphoma. Leukemia and Lymphoma 1996, 20: 249-257.
55. Sanches-Nieto B, Sánches-Doblado F, Terrón J A. A CT-aided PC-based physical treatment planning of TBI: a method for dose calculation. Radiotherapy and Oncology 1997, 42: 77-85.
56. Sanders J E et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total body irradiation and bone marrow transplantation. Blood 1996, 87: 3045-52.
57. Sanders J E, Hawley J, Levy W, Gooley T, Buckner C D, Deeg H J, Doney K, Storb R, Sullivan K, Witherspoon R, Appelbaum F R. Pubertal development of children with marrow transplantation before puberty. Journal of Pediatrics 1997, 130 (2): 174-175.
58. Santos G W, Tutscha P J, Brookmayer R. Marrow transplantation for acute non-lymphocytic leukaemia after treatment with busulphan and cyclophosphamide. New England Journal of Medicine 1983,309: 1347.
59. Sarafoglou K, Boulad F, Gillio A, Skalar C. Gonadal function after bone marrow transplantation for acute leukaemia during childhood. Journal of Pediatrics 1997,130 (2): 210-216.
60. Senn J S, McCulloch E A. Radiation sensitivity of human bone marrow cells measured by a cell culture method. Blood 1970, 35: 56-60.
61. Shank B, Chu F C H, Dinsmore R, Kapoor N, Kirkpatrick D, Teitelbaum H, Reid A, Bonfiglio P, Simpson L, O'Reilly R J. Hyperfractionated total body irradiation for bone marrow transplantation. Results in seventy leukaemia patients with allogeneic transplants. International Journal of Radiation Oncology - Biology - Physics 1983, 9: 1607-1611.
62. Slavin S, Narrastek E, Weshler Z, Brautbar C, Rachmilewitz E A, Fuks Z. Bone marrow transplantation for severe aplastic anaemia in HLA identical sibings using total lymphoid irradiation and cyclophosphamide. Transplantation Proceedings 1983, 15: 668-70.
63. Spitzer T R, Bryson J C, Cirenza E, Foelber R, Wallerstadt M, Stout C, Kunka R, Plagge P B, Dubois A. Randomized double blind placebo controlled evaluation of oral ondansetron in the prevention of nausea and vomiting associated with fractionated total body irradiation. Journal of Clinical Oncology 1994, 12: 2432-2438.
64. Stram D 0, Matthay K K, O'Leary M, Reynolds C P, Haase G M, Atkinson J B, Brodeur G M, Seeger R C. Consolodation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: A report of two concurrent Children's Cancer Group studies. Journal of Clinical Oncology 1996, 14 (9): 2417-2426.
65. Strober S, Tanay A, Field E, Hoppe R T, Calin A, Engleman E G, Kotzin B, Brown B W, Kaplan H S. Efficacy of total lymphoid irradiation in intractable rheumatoid arthritis. Annals of Internal Medicine 1985, 102: 441-9.
66. Sutherland H J, Fyles G M, Adams G, Hao Y, Lipton J H, Minden M D, Meharchand J M, Atkins H, Tejpar I, Messner H A. Quality of life following bone marrow transplantation: a comparison of patient reports with population norms. Bone Marrow Transplantation 1997,19: 1129·1136.
67. Sweetenham J W, Pearce R, Philip T, Proctor S J, Mandelli F, Colombat P, Goldstone A H. Hogh dose therapy and bone marrow transplantation for intermediate and high grade non-Hodgkin's lymphoma in patients aged 55 years and over: results from the European Group for Bone Marrow Transplantation. Bone Marrow Transplantation 1994, 14: 981-987.
68. Tarbell N J, Amato D A, down J D, Mauch P, Hellman S. Fractionation and dose rate effects in mice - a model for bone marrow transplantation in man. International Journal of Radiation Oncology - biology - Physics 1989,13: 1065-9.
69. Tarbell N J, Guinan E C, Niemeyer C, Mauch P, Sallan S E, Weinstein J H. Late onset of renal dysfunction in survivors of bone marrow transplantation. International Journal of Radiation Oncology - Biology - Physics 1988, 15: 99-104.
70. Thomas E D. Buckner C D, Clift R A, Fefer A. Johnson F L, Neiman P E, Sale G E, Sanders J E. Singer J W, Shulman H, Storb R. Weiden P L. Marrow transplantation for acute nonlymphoblastic leukemia in first remission. New England Journal of Medicine 1979,301: 597-9.
71. Thomas E D, Lochte H L, Luw C, Ferrebee J W. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. New England Journal of Medicine 1957, 257: 495-6.
72. Till J E, McCulloch E A. The sensitivity of cells from normal mouse bone marrow to gamma irradiation in vitro and in vivo. Radiation Research 1962, 16: 822· 32.
73. Toubert M E, Socie G, Gluckman E, Aractingi S, Esperon H, Deverige A, Ribaud P, Parquet N. Schlageter M H, Beressi J P, Rain J D, Vexian P. Short- and long-term follow-up of thyroid dysfunction after allogeneic bone marrow transplantation without the use of preparative total body irradiation. British Journal of Haematology 1997,98: 453-457.
74. Uchun F M, Chang W S, Nesbit M, Kersey J H, Ramsay N K C. Immunophenotype predicts radiation resistance in T - Iineagw acute lymphoblastic leukemia and T-Iineage non-Hodgkin's lumphoma. International Journal of Radiation Oncology - Biology - Physics 1992, 24: 705-712.
75. Van Besien K W, Khouri I F, Giralt S A, McCarthy P, Mehra R, Andersson B S, Przepiórka D, Gajewski J L, Bellare N, Nath R, et al. Allogeneic bone marrow transplantation for refractory and recurrent low grade lymphoma: the case for aggressive management. Journal of Clinical Oncology 1995, 13: 1096-1102.
76. Van Dam J, Rijnders A. Vanuytsel L, Zhang H Z. Practical implications of backscatter from outside the patient on the dose distribution during total body irradiation. Radiotherapy and Oncology 1988, 13: 193-201.
77. Varterasian M, Janakiraman N, Karanes C, Abella E, Uberti J, Dragovic J, Raman S B, Al-Katib A, Du W, Silver S M, Adams P T, Sensenbrenner L, Ratanatharathorn V. Transplantation in patients with multiple myeloma. American Journal of Clinical Oncology 1997, 20 (5): 462-466.
78. Westbrook C, Glaholm J, Barrett A. Vomiting associated with whole body irradiation. Clinical Radiology 1987, 38: 263-6.
79. Zhang M J, Hoelzer D et al. Long term follow up of adults with acute Iymphoblastc leukaemia in first remission treated with chemotherapy or bone marrow transplantation. Annals of Internal Medicine 1995, 123: 428-431.
80. Zittoun R A, Mandelli I F, Willemze R, De Witte T, Laba B, Resegotti L, Leoni F, Damasio E, Visani G, Papa Giuseppe, Caronia F, Hayat M, Stryckmans P, Rotoli B, Leoni P, Peetermans M E, Dardenne M, Vegna M L, Petti M C, Solbu G, Suciu S. Autologous and allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukaemia. New England Journal of Medicine 1995,332: 217.